Featured Events

Cardiovascular disease presented by Dr Ross Walker - Adelaide



Event Location

Date: 22nd February 2018
Location: Stamford Plaza Adelaide, Boulevard Room 150 North Terrace ADELAIDE SA Australia 5000


Event Details

Cardiovascular disease – our genes load the gun and our environment pulls the trigger

Improving our knowledge on the risk factors and correct assessment of patients will significantly improve how patients are managed and support their achievement of a normal, healthy lifespan.
Over the past decade, there has been increasing work and evidence for the importance of genetics in CVD, along with the burgeoning topics of epigenetics and nutrigenomics. With greater understanding in these areas, health professionals will be able to offer more targeted, personalised therapy.
There are many misconceptions around the causes and long-term management of CVD. For too long, there has been an emphasis on cholesterol levels as a major cause for CVD. With this excessive emphasis on cholesterol, its poorer cousin, hypertension, has often been ignored. And, in many cases, it goes undetected or under-treated. This is despite the fact that hypertension is, no doubt, the chief risk factor for CVD.
Cardiovascular disease (CVD) remains the major cause of death and disability around the world, with one Australian dying every 12 minutes from some form of this condition. The most common forms of CVD are the clinical syndromes related to atherosclerosis.
Program
Registration & Dinner           6:30pm - 7:00pm
Presentation                         7:00pm - 9:00pm
Q&A                                      9:00pm - 9:15pm


Registration                                                 NOW OPEN

Seminar Dates                                           Thursday 22 February 2018

Learning objectives   

  • To understand the relevance of the entire lipid profile in healthy people as well as those with evidence of atherosclerotic CVD.
  • To understand the importance of insulin resistance as a central feature of atherosclerotic CVD.
  • To understand the place of pharmaceutical and complementary therapies in the management of hyperlipidaemia and/or atherosclerotic CVD.
  • To comprehend the central role of hypertension in the generation of most forms of CVD.
  • To acknowledge the role of multiple genetic and environmental factors in the generation of hypertension.
  • To learn the best diagnostic approach to the treatment of people with hypertension.
  • To understand the non-pharmacologic and pharmacologic approaches to the treatment of hypertension.
  • To understand the role of genetics and epigenetics in CVD and diabetes.
  • To define and assess the role of the emerging field of nutrigenomics.
  • To understand the meaning and applicability of gene polymorphisms for the management of CVD.


-
-


Venue Information



Our Speakers



Ref: #1713890732-3